Sign in

CIK 0000885590

  • Large accelerated filer

Bausch Health Companies Inc.

Sign in to watch
Ticker
BHC
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NJ
Entity type
Operating
Phone
+1 514-744-6792
Business address
2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
Former names
Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
  1. 4 Grant or award Director acquired 852 shares (grant or award)
  2. 4 Grant or award Director acquired 7,754 shares (grant or award)
  3. 4 Grant or award Director acquired 4,109 shares (grant or award)
  4. 4 Planned sale EVP, General Counsel sold 440 shares at $8.35 ($3,674)
  5. 4 Grant or award Director acquired 842 shares (grant or award)
  6. 4 Grant or award Director acquired 4,059 shares (grant or award)
  7. 4 Grant or award Director acquired 7,659 shares (grant or award)
  8. 4 Planned sale EVP, General Counsel sold 13,370 shares at $6.21 ($83,028)
  9. 4 Shares withheld for taxes SVP, Controller & CAO gave up 3,982 shares (to pay taxes)
  10. 4 Shares withheld for taxes Chief Executive Officer gave up 14,683 shares (to pay taxes)
  11. 4 Grant or award EVP, CFO acquired 298,838 shares (grant or award)
  12. 3 Insider Initial Statement of Ownership
  13. 4 Grant or award SVP, Controller & CAO acquired 49,254 shares (grant or award)
  14. 4 Grant or award EVP, US Pharma acquired 144,352 shares (grant or award)
  15. 3 Insider Initial Statement of Ownership
  16. 4 Grant or award Director acquired 986 shares (grant or award)
  17. 4 Grant or award Director acquired 4,752 shares (grant or award)
  18. 4 Grant or award Director acquired 8,967 shares (grant or award)
  19. 4 Shares withheld for taxes SVP, Controller & CAO gave up 1,930 shares (to pay taxes)
  20. 4/A Grant or award SVP, Controller & CAO acquired 39,126 shares (grant or award)

Page 5 of 61 · 1,214 filings